These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 31734262)

  • 1. Molecular mechanism of celastrol in the treatment of systemic lupus erythematosus based on network pharmacology and molecular docking technology.
    Xinqiang S; Yu Z; Ningning Y; Erqin D; Lei W; Hongtao D
    Life Sci; 2020 Jan; 240():117063. PubMed ID: 31734262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of celastrol against rheumatoid arthritis: A network pharmacology analysis.
    Song X; Zhang Y; Dai E; Du H; Wang L
    Int Immunopharmacol; 2019 Sep; 74():105725. PubMed ID: 31276975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multi-targets mechanism of hydroxychloroquine in the treatment of systemic lupus erythematosus based on network pharmacology.
    Xie B; Geng Q; Xu J; Lu H; Luo H; Hu Y; Song X
    Lupus; 2020 Nov; 29(13):1704-1711. PubMed ID: 32854577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Network Pharmacology and Molecular Docking Strategy to Explore Potential Targets and Mechanisms Underlying the Effect of Curcumin on Osteonecrosis of the Femoral Head in Systemic Lupus Erythematosus.
    Kang P; Wu Z; Zhong Y; Wang Z; Zhou C; Huo S; Guo H; Li S; Xu K; Liu L; Chen S; Tang H; Wang H
    Biomed Res Int; 2021; 2021():5538643. PubMed ID: 34557547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of
    Jaiswal S; Kumar S; Sarkar B; Sinha RK
    Lupus; 2024 Oct; 33(11):1155-1167. PubMed ID: 39135520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of QH-BJ drug pair in the treatment of systemic lupus erythematosus based on network pharmacology and molecular docking.
    Song Z; Ji L; Wu S; Fan Y; Zhang Q; Yang K; Fang S
    Medicine (Baltimore); 2022 Dec; 101(48):e32062. PubMed ID: 36482627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics.
    Zeng L; Yu G; Yang K; He Q; Hao W; Xiang W; Long Z; Chen H; Tang X; Sun L
    Sci Rep; 2024 Jan; 14(1):1604. PubMed ID: 38238321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative transcriptomics and network pharmacology analysis to identify the potential mechanism of celastrol against osteoarthritis.
    Dai S; Wang H; Wang M; Zhang Y; Zhang Z; Lin Z
    Clin Rheumatol; 2021 Oct; 40(10):4259-4268. PubMed ID: 33870466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes.
    Wu M; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():1030278. PubMed ID: 36339449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Promising Target of Langchuangding Prescription Treating Systemic Lupus Erythaematosus Integrated Network Pharmacology with HPLC-MS and Molecular Docking.
    Li Q; Sun J; Tu J; Li H; Zhang J; Gu H; Xie Z; Lv H
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):307. PubMed ID: 36472105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of triptolide targets in rheumatoid arthritis using network pharmacology and molecular docking.
    Song X; Zhang Y; Dai E; Wang L; Du H
    Int Immunopharmacol; 2020 Mar; 80():106179. PubMed ID: 31972422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targets of
    Xiao L; Xiao W; Zhan F
    Lupus; 2022 Mar; 31(3):319-329. PubMed ID: 35067081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations.
    Ling J; Huang Y; Sun Z; Guo X; Chang A; Pan J; Zhuo X
    Front Pharmacol; 2022; 13():996728. PubMed ID: 36506508
    [No Abstract]   [Full Text] [Related]  

  • 14. Identifying the Effect of Celastrol Against Ovarian Cancer With Network Pharmacology and
    Wang X; Liu Q; Wu S; Xu N; Li H; Feng A
    Front Pharmacol; 2022; 13():739478. PubMed ID: 35370699
    [No Abstract]   [Full Text] [Related]  

  • 15. Network pharmacology modeling identifies synergistic interaction of therapeutic and toxicological mechanisms for Tripterygium hypoglaucum Hutch.
    Zhang D; Dong Y; Lv J; Zhang B; Zhang X; Lin Z
    BMC Complement Med Ther; 2021 Jan; 21(1):38. PubMed ID: 33446184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of IKKβ by celastrol and its analogues - an in silico and in vitro approach.
    Veerappan K; Natarajan S; Ethiraj P; Vetrivel U; Samuel S
    Pharm Biol; 2017 Dec; 55(1):368-373. PubMed ID: 27931154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network Pharmacology and Experimental Validation to Explore That Celastrol Targeting PTEN is the Potential Mechanism of
    Zhao J; Liu H; Xia M; Chen Q; Wan L; Leng B; Tang C; Chen G; Liu Y; Zhang L; Liu H
    Drug Des Devel Ther; 2023; 17():887-900. PubMed ID: 36992900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celastrol inhibits inflammatory stimuli-induced neutrophil extracellular trap formation.
    Yu Y; Koehn CD; Yue Y; Li S; Thiele GM; Hearth-Holmes MP; Mikuls TR; O'Dell JR; Klassen LW; Zhang Z; Su K
    Curr Mol Med; 2015; 15(4):401-10. PubMed ID: 25941817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of CLEC2B as a diagnostic biomarker and screening of celastrol as a candidate drug for psoriatic arthritis through bioinformatics analysis.
    Niu M; Yuan J; Yan M; Yang G; Yan Z; Yang X
    J Orthop Surg Res; 2023 May; 18(1):390. PubMed ID: 37246213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
    Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
    J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.